Phospho-EGF Receptor (Tyr998) Antibody [L7A22]

Application: Reactivity: Human

Usage Information

Dilution
WB1:1000 IP1:50

Application
WB, IP

Reactivity
Human

Source
Rabbit Monoclonal Antibody

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW
175 kDa

Datasheet & SDS

Biological Description

Specificity
Phospho-EGF Receptor (Tyr998) Antibody [L7A22] detects endogenous levels of total EGF Receptor protein only when it is phosphorylated at Tyr998.

Clone
L7A22

Synonym(s)
Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, EGFR, ERBB, ERBB1, HER1

Background
Phospho–EGF receptor (Tyr998) represents a ligand-inducible regulatory state of EGFR in which a tyrosine within the juxtamembrane/proximal cytoplasmic region is phosphorylated with delayed kinetics and participates primarily in the control of receptor endocytosis and trafficking rather than in classical Ras–ERK signal initiation. The receptor itself is a HER/ErbB-family type I transmembrane kinase with an extracellular ligand-binding ectodomain, a single-pass transmembrane helix, an intracellular tyrosine kinase domain, and a C‑terminal tail harboring multiple canonical autophosphorylation sites and serine/threonine clusters; Tyr998 lies N‑terminal to these major docking tyrosines and is phosphorylated together with nearby Ser991 as part of a distinct multisite phosphorylation cassette. Quantitative phosphoproteomics of EGF-stimulated carcinoma cells shows that phosphorylation at Tyr998 and Ser991 accumulates more slowly than at classical signaling sites such as Tyr1068 and Tyr1173, while receptors carrying the Y998F or S991A substitutions retain robust ERK activation and maintain EGF-stimulated GRB2 binding, indicating that Tyr998 is dispensable for proximal Ras–ERK signaling but contributes to a later regulatory phase. Specific requirement of Tyr998 and Ser991 for efficient clathrin-mediated endocytosis: Y998F and S991A receptors show impaired internalization despite normal kinase activation, reduced association of EGFR with the E3 ligase CBL, and decreased receptor ubiquitination, which collectively delay sorting into degradative pathways. Trafficking-defective Y998F and S991A receptors exhibit elevated phosphorylation of a downstream serine/threonine cluster at Ser1039 and Thr1041, residues controlled by p38 MAP kinase and previously implicated in stress-induced internalization and recycling, and pharmacologic inhibition of p38 reduces Ser1039/Thr1041 phosphorylation and alters receptor trafficking dynamics, pointing to a coordinated phosphorylation network in which Tyr998 and Ser991 “license” subsequent p38‑dependent modifications that fine-tune endocytosis and recycling. In this model, Tyr998 phosphorylation functions as part of a spatial and temporal code that links the early autophosphorylation pattern at classical docking sites to the later recruitment of CBL, ubiquitin machinery, and p38‑regulated trafficking factors, shaping the balance between sustained surface signaling and receptor downregulation in response to EGF.

Background

Phospho–EGF receptor (Tyr998) represents a ligand-inducible regulatory state of EGFR in which a tyrosine within the juxtamembrane/proximal cytoplasmic region is phosphorylated with delayed kinetics and participates primarily in the control of receptor endocytosis and trafficking rather than in classical Ras–ERK signal initiation. The receptor itself is a HER/ErbB-family type I transmembrane kinase with an extracellular ligand-binding ectodomain, a single-pass transmembrane helix, an intracellular tyrosine kinase domain, and a C‑terminal tail harboring multiple canonical autophosphorylation sites and serine/threonine clusters; Tyr998 lies N‑terminal to these major docking tyrosines and is phosphorylated together with nearby Ser991 as part of a distinct multisite phosphorylation cassette. Quantitative phosphoproteomics of EGF-stimulated carcinoma cells shows that phosphorylation at Tyr998 and Ser991 accumulates more slowly than at classical signaling sites such as Tyr1068 and Tyr1173, while receptors carrying the Y998F or S991A substitutions retain robust ERK activation and maintain EGF-stimulated GRB2 binding, indicating that Tyr998 is dispensable for proximal Ras–ERK signaling but contributes to a later regulatory phase. Specific requirement of Tyr998 and Ser991 for efficient clathrin-mediated endocytosis: Y998F and S991A receptors show impaired internalization despite normal kinase activation, reduced association of EGFR with the E3 ligase CBL, and decreased receptor ubiquitination, which collectively delay sorting into degradative pathways. Trafficking-defective Y998F and S991A receptors exhibit elevated phosphorylation of a downstream serine/threonine cluster at Ser1039 and Thr1041, residues controlled by p38 MAP kinase and previously implicated in stress-induced internalization and recycling, and pharmacologic inhibition of p38 reduces Ser1039/Thr1041 phosphorylation and alters receptor trafficking dynamics, pointing to a coordinated phosphorylation network in which Tyr998 and Ser991 “license” subsequent p38‑dependent modifications that fine-tune endocytosis and recycling. In this model, Tyr998 phosphorylation functions as part of a spatial and temporal code that links the early autophosphorylation pattern at classical docking sites to the later recruitment of CBL, ubiquitin machinery, and p38‑regulated trafficking factors, shaping the balance between sustained surface signaling and receptor downregulation in response to EGF.

References
https://pubmed.ncbi.nlm.nih.gov/19531499/ https://pubmed.ncbi.nlm.nih.gov/15657067/

Reference Table for Selecting PVDF Membrane Pore Size Specifications

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%